News & Events
Latest Blog Posts
-
Nivolumab Injections Could Make Cancer Treatment Easier
In a clinical trial, an injectable form of the immunotherapy drug worked as well against tumors as the IV form.
-
Cancer Risk Among Childhood Cancer Survivors
New study looks at the role of common inherited genetic factors in the development of subsequent cancers.
-
Cancer Grand Challenges Selects New Teams
Global teams will tackle cancer inequities, early-onset cancers, solid tumors in children, and T-cell receptors.
Latest Press Releases
-
For childhood cancer survivors, inherited genetic factors influence risk of cancers later in life
Common inherited genetic factors that predict cancer risk in the general population may also predict elevated risk of new cancers among childhood cancer survivors. Findings could potentially inform screening and long-term follow-up of those at greatest risk.
-
Cancer Grand Challenges selects five new global, interdisciplinary teams to take on four challenges
Interdisciplinary teams will address the following challenges: reducing cancer inequities, understanding the mechanisms of early-onset cancers, developing drugs for solid tumors in children, and broadening our knowledge about how T cells recognize cancer cells.
-
NIH to address dwindling clinical trial patient enrollment with centralized staffing support
The Virtual Clinical Trials Office aims to tackle the steep decline in participation in NCI-
funded cancer clinical trials by providing a centralized team of support staff working
remotely to assist with NCI-funded clinical trials activities.
-
NIH launches research network to evaluate emerging cancer screening technologies
The Cancer Screening Research Network (CSRN) will investigate how to identify cancers earlier, when they may be easier to treat, to ultimately save lives. In late 2024, CSRN plans to launch the Vanguard Study on Multi-Cancer Detection, a pilot study to inform the design of a larger trial of multi-cancer detection tests.
-
W. Kimryn Rathmell begins work as 17th director of the National Cancer Institute
W. Kimryn Rathmell, M.D., Ph.D., begins her tenure as the 17th director of the National Cancer Institute on December 18, 2023. She comes to NCI from Vanderbilt University Medical Center in Nashville, Tennessee, where she served as the Hugh Jackson Morgan Chair in Medicine, chair of the Department of Medicine, and physician-in-chief.
Media Resources
Cancer Currents Blog
Find news and updates on the latest cancer research.